Drug intelligence / Profile preview

bromodiphenhydramine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Bromodiphenhydramine (also known as bromazine) is an ethanolamine-class antihistamine and anticholinergic medication. It is a structural analogue of diphenhydramine with a bromine atom substituted on one of the phenyl rings. Bromodiphenhydramine acts primarily as a competitive antagonist at histamine H1 receptor, thereby reducing symptoms caused by histamine release such as those seen in allergies and hay fever. In addition to its antihistaminic effects, it has significant antimuscarinic activity that contributes to marked sedation and antiemetic properties. The drug is used for the control of cutaneous allergies, management of symptoms related to hay fever and other types of allergy, relief from irritant coughs and motion sickness (nausea, vomiting, vertigo), treatment of drug-induced extrapyramidal symptoms, and mild cases of Parkinson's disease[1][5][6][7]. Its central antimuscarinic effect likely accounts for its antidyskinetic action.

Brand names
AmbodrylAmbrodilDeserol
Other names
bromazine
02

Targets

mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on bromodiphenhydramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bromodiphenhydramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call